| Item Type | Name |
|
Concept
|
Diabetes Mellitus, Type 1
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Diabetes Complications
|
|
Concept
|
Diabetes Mellitus
|
|
Academic Article
|
Fiber intake and risk of developing non-insulin-dependent diabetes mellitus.
|
|
Academic Article
|
Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia.
|
|
Academic Article
|
Risk of cardiovascular disease and sudden death in schizophrenia.
|
|
Academic Article
|
Combination lipid-lowering therapy in diabetes.
|
|
Academic Article
|
C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
|
|
Academic Article
|
The FIELD Study and reduction of cardiovascular events in patients with diabetes.
|
|
Academic Article
|
Global risk management in patients with type 2 diabetes mellitus.
|
|
Academic Article
|
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
|
|
Academic Article
|
Reducing residual risk for patients on statin therapy: the potential role of combination therapy.
|
|
Academic Article
|
Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
|
|
Academic Article
|
The PROACTIVE Study and reduction of cardiovascular events in patients with diabetes.
|
|
Academic Article
|
Statin safety: an assessment using an administrative claims database.
|
|
Academic Article
|
Inhaled human insulin: an inspiration for patients with diabetes mellitus?
|
|
Academic Article
|
New concepts in dyslipidemia in the metabolic syndrome and diabetes.
|
|
Academic Article
|
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
|
|
Academic Article
|
Should every patient with diabetes receive a statin?
|
|
Academic Article
|
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
|
|
Academic Article
|
Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes.
|
|
Academic Article
|
Treating dyslipidemia in high-risk patients: case reviews and discussion.
|
|
Academic Article
|
ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabili...
|
|
Academic Article
|
The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus.
|
|
Academic Article
|
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
|
|
Academic Article
|
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
|
|
Academic Article
|
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk.
|
|
Academic Article
|
Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study.
|
|
Academic Article
|
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
|
|
Academic Article
|
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
|
|
Academic Article
|
Statin and ezetimibe combination therapy in cardiovascular disease.
|
|
Academic Article
|
Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence.
|
|
Academic Article
|
Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus.
|
|
Academic Article
|
Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes.
|
|
Academic Article
|
The use of high-sensitivity assays for C-reactive protein in clinical practice.
|
|
Academic Article
|
Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet.
|
|
Academic Article
|
Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes.
|
|
Academic Article
|
Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
|
|
Academic Article
|
Cardio-diabetes: special considerations for the patient with diabetes and cardiovascular disease. Introduction.
|
|
Academic Article
|
Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist.
|
|
Academic Article
|
Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses.
|
|
Academic Article
|
Type 2 diabetes and cardiovascular disease: reducing the risk.
|
|
Academic Article
|
Apolipoprotein measurements: is more widespread use clinically indicated?
|
|
Academic Article
|
ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabili...
|
|
Academic Article
|
Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
|
|
Academic Article
|
Diabetes mellitus in midlife and the risk of dementia three decades later.
|
|
Academic Article
|
Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study.
|
|
Academic Article
|
The ASPEN Study and reduction of cardiovascular events in patients with diabetes.
|
|
Academic Article
|
Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes.
|
|
Academic Article
|
A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
|
|
Academic Article
|
The role of cardiologists in the management of patients with diabetes is evolving owing to the close relationship between diabetes and CAD. Introduction.
|
|
Academic Article
|
Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life.
|
|
Academic Article
|
Reducing the risk of stroke through appropriate targets and treatments.
|
|
Academic Article
|
Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus.
|
|
Academic Article
|
Impaired diurnal blood pressure variation and all-cause mortality.
|
|
Academic Article
|
Pharmacotherapy: Implications of high-dose statin link with incident diabetes.
|
|
Academic Article
|
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.
|
|
Academic Article
|
Effect of spironolactone therapy on albuminuria in patients with type 2 diabetes treated with angiotensin-converting enzyme inhibitors.
|
|
Academic Article
|
AACE comprehensive diabetes management algorithm 2013.
|
|
Academic Article
|
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.
|
|
Academic Article
|
A STUDY OF BLOOD GLUCOSE AND KETONE BODIES AND PLASMA FREE FATTY ACIDS, CHOLESTEROL, PHOSPHOLIPIDS AND TOTAL LIPIDS IN JUVENILE DIABETES.
|
|
Academic Article
|
Accidental hypothermia: a community hospital perspective.
|
|
Academic Article
|
Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments.
|
|
Academic Article
|
Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus.
|
|
Academic Article
|
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.
|
|
Academic Article
|
LIMITATIONS IN THE USE OF ORAL HYPOGLYCEMIC AGENTS IN JUVENILE PATIENTS WITH DIABETES.
|
|
Academic Article
|
AACE/ACE comprehensive diabetes management algorithm 2015.
|
|
Academic Article
|
The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?
|
|
Academic Article
|
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
|
|
Academic Article
|
Short-term effects of coping skills training as adjunct to intensive therapy in adolescents.
|